Sutro Biopharma to Participate in Four Upcoming Investor Conferences

On November 11, 2020 Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development, and manufacturing company, reported that Chief Executive Officer, Bill Newell, will participate in four upcoming virtual conferences in November and December of 2020 (Press release, Sutro Biopharma, NOV 11, 2020, View Source [SID1234570625]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentations Details:

2020 Stifel Virtual Healthcare Conference
Format: Corporate Presentation
Date: Monday, Nov. 16, 2020
Time: 3:20pm ET / 12:20pm PT

Jefferies Virtual London Healthcare Conference
Format: Virtual Fireside Chat
Date: Thursday, Nov. 19, 2020
Time: 12:35pm ET / 9:35am PT / 5:35pm GMT

Piper Sandler 32nd Annual Healthcare Conference
Format: Virtual Fireside Chat
Date: Tuesday, Dec. 1-3, 2020
Note: Fireside Discussion Available Nov. 23 through Dec. 3

3rd Annual Evercore ISI HealthCONx Conference
Format: Virtual Fireside Chat
Date: Thursday, Dec. 3, 2020
Time: 10:30am ET / 7:30am PT

Live webcasts of each presentation can be accessed through the Events and Presentations page of the Investor Relations section on the company’s website at www.sutrobio.com. Archived replays of the webcasts will be available on the company’s website for approximately 30 days following each live presentation.